Contraceptives-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Contraceptives-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Contraceptives industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Contraceptives 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Contraceptives worldwide and market share by regions, with company and product introduction, position in the Contraceptives market
Market status and development trend of Contraceptives by types and applications
Cost and profit status of Contraceptives, and marketing status
Market growth drivers and challenges
The report segments the global Contraceptives market as:
Global Contraceptives Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Contraceptives Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral Contraceptive Pills
Injectables
Topical
Global Contraceptives Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
Global Contraceptives Market: Manufacturers Segment Analysis (Company and Product introduction, Contraceptives Sales Volume, Revenue, Price and Gross Margin):
The Female Health Company
Teva Pharmaceutical
Reckitt Benckiser
Pfizer
Mayer Laboratories
Cooper Surgical
Church & Dwight
Actavis
Merck & Co.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Contraceptives-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Contraceptives industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Contraceptives 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Contraceptives worldwide and market share by regions, with company and product introduction, position in the Contraceptives market
Market status and development trend of Contraceptives by types and applications
Cost and profit status of Contraceptives, and marketing status
Market growth drivers and challenges
The report segments the global Contraceptives market as:
Global Contraceptives Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Contraceptives Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral Contraceptive Pills
Injectables
Topical
Global Contraceptives Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
Global Contraceptives Market: Manufacturers Segment Analysis (Company and Product introduction, Contraceptives Sales Volume, Revenue, Price and Gross Margin):
The Female Health Company
Teva Pharmaceutical
Reckitt Benckiser
Pfizer
Mayer Laboratories
Cooper Surgical
Church & Dwight
Actavis
Merck & Co.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CONTRACEPTIVES
1.1 Definition of Contraceptives in This Report
1.2 Commercial Types of Contraceptives
1.2.1 Oral Contraceptive Pills
1.2.2 Injectables
1.2.3 Topical
1.3 Downstream Application of Contraceptives
1.3.1 Male
1.3.2 Female
1.4 Development History of Contraceptives
1.5 Market Status and Trend of Contraceptives 2013-2023
1.5.1 Global Contraceptives Market Status and Trend 2013-2023
1.5.2 Regional Contraceptives Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Contraceptives 2013-2017
2.2 Sales Market of Contraceptives by Regions
2.2.1 Sales Volume of Contraceptives by Regions
2.2.2 Sales Value of Contraceptives by Regions
2.3 Production Market of Contraceptives by Regions
2.4 Global Market Forecast of Contraceptives 2018-2023
2.4.1 Global Market Forecast of Contraceptives 2018-2023
2.4.2 Market Forecast of Contraceptives by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Contraceptives by Types
3.2 Sales Value of Contraceptives by Types
3.3 Market Forecast of Contraceptives by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Contraceptives by Downstream Industry
4.2 Global Market Forecast of Contraceptives by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Contraceptives Market Status by Countries
5.1.1 North America Contraceptives Sales by Countries (2013-2017)
5.1.2 North America Contraceptives Revenue by Countries (2013-2017)
5.1.3 United States Contraceptives Market Status (2013-2017)
5.1.4 Canada Contraceptives Market Status (2013-2017)
5.1.5 Mexico Contraceptives Market Status (2013-2017)
5.2 North America Contraceptives Market Status by Manufacturers
5.3 North America Contraceptives Market Status by Type (2013-2017)
5.3.1 North America Contraceptives Sales by Type (2013-2017)
5.3.2 North America Contraceptives Revenue by Type (2013-2017)
5.4 North America Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Contraceptives Market Status by Countries
6.1.1 Europe Contraceptives Sales by Countries (2013-2017)
6.1.2 Europe Contraceptives Revenue by Countries (2013-2017)
6.1.3 Germany Contraceptives Market Status (2013-2017)
6.1.4 UK Contraceptives Market Status (2013-2017)
6.1.5 France Contraceptives Market Status (2013-2017)
6.1.6 Italy Contraceptives Market Status (2013-2017)
6.1.7 Russia Contraceptives Market Status (2013-2017)
6.1.8 Spain Contraceptives Market Status (2013-2017)
6.1.9 Benelux Contraceptives Market Status (2013-2017)
6.2 Europe Contraceptives Market Status by Manufacturers
6.3 Europe Contraceptives Market Status by Type (2013-2017)
6.3.1 Europe Contraceptives Sales by Type (2013-2017)
6.3.2 Europe Contraceptives Revenue by Type (2013-2017)
6.4 Europe Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Contraceptives Market Status by Countries
7.1.1 Asia Pacific Contraceptives Sales by Countries (2013-2017)
7.1.2 Asia Pacific Contraceptives Revenue by Countries (2013-2017)
7.1.3 China Contraceptives Market Status (2013-2017)
7.1.4 Japan Contraceptives Market Status (2013-2017)
7.1.5 India Contraceptives Market Status (2013-2017)
7.1.6 Southeast Asia Contraceptives Market Status (2013-2017)
7.1.7 Australia Contraceptives Market Status (2013-2017)
7.2 Asia Pacific Contraceptives Market Status by Manufacturers
7.3 Asia Pacific Contraceptives Market Status by Type (2013-2017)
7.3.1 Asia Pacific Contraceptives Sales by Type (2013-2017)
7.3.2 Asia Pacific Contraceptives Revenue by Type (2013-2017)
7.4 Asia Pacific Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Contraceptives Market Status by Countries
8.1.1 Latin America Contraceptives Sales by Countries (2013-2017)
8.1.2 Latin America Contraceptives Revenue by Countries (2013-2017)
8.1.3 Brazil Contraceptives Market Status (2013-2017)
8.1.4 Argentina Contraceptives Market Status (2013-2017)
8.1.5 Colombia Contraceptives Market Status (2013-2017)
8.2 Latin America Contraceptives Market Status by Manufacturers
8.3 Latin America Contraceptives Market Status by Type (2013-2017)
8.3.1 Latin America Contraceptives Sales by Type (2013-2017)
8.3.2 Latin America Contraceptives Revenue by Type (2013-2017)
8.4 Latin America Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Contraceptives Market Status by Countries
9.1.1 Middle East and Africa Contraceptives Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Contraceptives Revenue by Countries (2013-2017)
9.1.3 Middle East Contraceptives Market Status (2013-2017)
9.1.4 Africa Contraceptives Market Status (2013-2017)
9.2 Middle East and Africa Contraceptives Market Status by Manufacturers
9.3 Middle East and Africa Contraceptives Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Contraceptives Sales by Type (2013-2017)
9.3.2 Middle East and Africa Contraceptives Revenue by Type (2013-2017)
9.4 Middle East and Africa Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CONTRACEPTIVES
10.1 Global Economy Situation and Trend Overview
10.2 Contraceptives Downstream Industry Situation and Trend Overview
CHAPTER 11 CONTRACEPTIVES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Contraceptives by Major Manufacturers
11.2 Production Value of Contraceptives by Major Manufacturers
11.3 Basic Information of Contraceptives by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Contraceptives Major Manufacturer
11.3.2 Employees and Revenue Level of Contraceptives Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CONTRACEPTIVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 The Female Health Company
12.1.1 Company profile
12.1.2 Representative Contraceptives Product
12.1.3 Contraceptives Sales, Revenue, Price and Gross Margin of The Female Health Company
12.2 Teva Pharmaceutical
12.2.1 Company profile
12.2.2 Representative Contraceptives Product
12.2.3 Contraceptives Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
12.3 Reckitt Benckiser
12.3.1 Company profile
12.3.2 Representative Contraceptives Product
12.3.3 Contraceptives Sales, Revenue, Price and Gross Margin of Reckitt Benckiser
12.4 Pfizer
12.4.1 Company profile
12.4.2 Representative Contraceptives Product
12.4.3 Contraceptives Sales, Revenue, Price and Gross Margin of Pfizer
12.5 Mayer Laboratories
12.5.1 Company profile
12.5.2 Representative Contraceptives Product
12.5.3 Contraceptives Sales, Revenue, Price and Gross Margin of Mayer Laboratories
12.6 Cooper Surgical
12.6.1 Company profile
12.6.2 Representative Contraceptives Product
12.6.3 Contraceptives Sales, Revenue, Price and Gross Margin of Cooper Surgical
12.7 Church & Dwight
12.7.1 Company profile
12.7.2 Representative Contraceptives Product
12.7.3 Contraceptives Sales, Revenue, Price and Gross Margin of Church & Dwight
12.8 Actavis
12.8.1 Company profile
12.8.2 Representative Contraceptives Product
12.8.3 Contraceptives Sales, Revenue, Price and Gross Margin of Actavis
12.9 Merck & Co.
12.9.1 Company profile
12.9.2 Representative Contraceptives Product
12.9.3 Contraceptives Sales, Revenue, Price and Gross Margin of Merck & Co.
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRACEPTIVES
13.1 Industry Chain of Contraceptives
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CONTRACEPTIVES
14.1 Cost Structure Analysis of Contraceptives
14.2 Raw Materials Cost Analysis of Contraceptives
14.3 Labor Cost Analysis of Contraceptives
14.4 Manufacturing Expenses Analysis of Contraceptives
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Contraceptives in This Report
1.2 Commercial Types of Contraceptives
1.2.1 Oral Contraceptive Pills
1.2.2 Injectables
1.2.3 Topical
1.3 Downstream Application of Contraceptives
1.3.1 Male
1.3.2 Female
1.4 Development History of Contraceptives
1.5 Market Status and Trend of Contraceptives 2013-2023
1.5.1 Global Contraceptives Market Status and Trend 2013-2023
1.5.2 Regional Contraceptives Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Contraceptives 2013-2017
2.2 Sales Market of Contraceptives by Regions
2.2.1 Sales Volume of Contraceptives by Regions
2.2.2 Sales Value of Contraceptives by Regions
2.3 Production Market of Contraceptives by Regions
2.4 Global Market Forecast of Contraceptives 2018-2023
2.4.1 Global Market Forecast of Contraceptives 2018-2023
2.4.2 Market Forecast of Contraceptives by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Contraceptives by Types
3.2 Sales Value of Contraceptives by Types
3.3 Market Forecast of Contraceptives by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Contraceptives by Downstream Industry
4.2 Global Market Forecast of Contraceptives by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Contraceptives Market Status by Countries
5.1.1 North America Contraceptives Sales by Countries (2013-2017)
5.1.2 North America Contraceptives Revenue by Countries (2013-2017)
5.1.3 United States Contraceptives Market Status (2013-2017)
5.1.4 Canada Contraceptives Market Status (2013-2017)
5.1.5 Mexico Contraceptives Market Status (2013-2017)
5.2 North America Contraceptives Market Status by Manufacturers
5.3 North America Contraceptives Market Status by Type (2013-2017)
5.3.1 North America Contraceptives Sales by Type (2013-2017)
5.3.2 North America Contraceptives Revenue by Type (2013-2017)
5.4 North America Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Contraceptives Market Status by Countries
6.1.1 Europe Contraceptives Sales by Countries (2013-2017)
6.1.2 Europe Contraceptives Revenue by Countries (2013-2017)
6.1.3 Germany Contraceptives Market Status (2013-2017)
6.1.4 UK Contraceptives Market Status (2013-2017)
6.1.5 France Contraceptives Market Status (2013-2017)
6.1.6 Italy Contraceptives Market Status (2013-2017)
6.1.7 Russia Contraceptives Market Status (2013-2017)
6.1.8 Spain Contraceptives Market Status (2013-2017)
6.1.9 Benelux Contraceptives Market Status (2013-2017)
6.2 Europe Contraceptives Market Status by Manufacturers
6.3 Europe Contraceptives Market Status by Type (2013-2017)
6.3.1 Europe Contraceptives Sales by Type (2013-2017)
6.3.2 Europe Contraceptives Revenue by Type (2013-2017)
6.4 Europe Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Contraceptives Market Status by Countries
7.1.1 Asia Pacific Contraceptives Sales by Countries (2013-2017)
7.1.2 Asia Pacific Contraceptives Revenue by Countries (2013-2017)
7.1.3 China Contraceptives Market Status (2013-2017)
7.1.4 Japan Contraceptives Market Status (2013-2017)
7.1.5 India Contraceptives Market Status (2013-2017)
7.1.6 Southeast Asia Contraceptives Market Status (2013-2017)
7.1.7 Australia Contraceptives Market Status (2013-2017)
7.2 Asia Pacific Contraceptives Market Status by Manufacturers
7.3 Asia Pacific Contraceptives Market Status by Type (2013-2017)
7.3.1 Asia Pacific Contraceptives Sales by Type (2013-2017)
7.3.2 Asia Pacific Contraceptives Revenue by Type (2013-2017)
7.4 Asia Pacific Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Contraceptives Market Status by Countries
8.1.1 Latin America Contraceptives Sales by Countries (2013-2017)
8.1.2 Latin America Contraceptives Revenue by Countries (2013-2017)
8.1.3 Brazil Contraceptives Market Status (2013-2017)
8.1.4 Argentina Contraceptives Market Status (2013-2017)
8.1.5 Colombia Contraceptives Market Status (2013-2017)
8.2 Latin America Contraceptives Market Status by Manufacturers
8.3 Latin America Contraceptives Market Status by Type (2013-2017)
8.3.1 Latin America Contraceptives Sales by Type (2013-2017)
8.3.2 Latin America Contraceptives Revenue by Type (2013-2017)
8.4 Latin America Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Contraceptives Market Status by Countries
9.1.1 Middle East and Africa Contraceptives Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Contraceptives Revenue by Countries (2013-2017)
9.1.3 Middle East Contraceptives Market Status (2013-2017)
9.1.4 Africa Contraceptives Market Status (2013-2017)
9.2 Middle East and Africa Contraceptives Market Status by Manufacturers
9.3 Middle East and Africa Contraceptives Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Contraceptives Sales by Type (2013-2017)
9.3.2 Middle East and Africa Contraceptives Revenue by Type (2013-2017)
9.4 Middle East and Africa Contraceptives Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CONTRACEPTIVES
10.1 Global Economy Situation and Trend Overview
10.2 Contraceptives Downstream Industry Situation and Trend Overview
CHAPTER 11 CONTRACEPTIVES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Contraceptives by Major Manufacturers
11.2 Production Value of Contraceptives by Major Manufacturers
11.3 Basic Information of Contraceptives by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Contraceptives Major Manufacturer
11.3.2 Employees and Revenue Level of Contraceptives Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CONTRACEPTIVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 The Female Health Company
12.1.1 Company profile
12.1.2 Representative Contraceptives Product
12.1.3 Contraceptives Sales, Revenue, Price and Gross Margin of The Female Health Company
12.2 Teva Pharmaceutical
12.2.1 Company profile
12.2.2 Representative Contraceptives Product
12.2.3 Contraceptives Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
12.3 Reckitt Benckiser
12.3.1 Company profile
12.3.2 Representative Contraceptives Product
12.3.3 Contraceptives Sales, Revenue, Price and Gross Margin of Reckitt Benckiser
12.4 Pfizer
12.4.1 Company profile
12.4.2 Representative Contraceptives Product
12.4.3 Contraceptives Sales, Revenue, Price and Gross Margin of Pfizer
12.5 Mayer Laboratories
12.5.1 Company profile
12.5.2 Representative Contraceptives Product
12.5.3 Contraceptives Sales, Revenue, Price and Gross Margin of Mayer Laboratories
12.6 Cooper Surgical
12.6.1 Company profile
12.6.2 Representative Contraceptives Product
12.6.3 Contraceptives Sales, Revenue, Price and Gross Margin of Cooper Surgical
12.7 Church & Dwight
12.7.1 Company profile
12.7.2 Representative Contraceptives Product
12.7.3 Contraceptives Sales, Revenue, Price and Gross Margin of Church & Dwight
12.8 Actavis
12.8.1 Company profile
12.8.2 Representative Contraceptives Product
12.8.3 Contraceptives Sales, Revenue, Price and Gross Margin of Actavis
12.9 Merck & Co.
12.9.1 Company profile
12.9.2 Representative Contraceptives Product
12.9.3 Contraceptives Sales, Revenue, Price and Gross Margin of Merck & Co.
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CONTRACEPTIVES
13.1 Industry Chain of Contraceptives
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CONTRACEPTIVES
14.1 Cost Structure Analysis of Contraceptives
14.2 Raw Materials Cost Analysis of Contraceptives
14.3 Labor Cost Analysis of Contraceptives
14.4 Manufacturing Expenses Analysis of Contraceptives
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
